Altos Labs was founded in 2022 by Richard D. Klausner and Hans Bishop. The company has not officially endorsed a plan to participate in an IPO. These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Altos is a biotech company dedicated to exploring cellular rejuvenation technologies with the goal of developing life extension therapies that could slow or stop the aging process. The company's board is composed of prominent scientific figures as well as four Nobel laureates. Altos launched with $3 billion in private funding, making it already one of the most well-funded biotech companies in the world. Investors include Jeff Bezos, Yuri Milner, and ARCH Venture Partners. The company has not released any valuation figures.